Skip to content
← Back to this collection

PUBLICATIONS · 18378568

Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2008 May 20
First author
Kelly K

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2008 May 20;26(15):2428-30. doi: 10.1200/JCO.2008.16.0374.
    note
    Source null
    related pmid
    18378565
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2008 Oct 10;26(29):4849-50; author reply 4850-1. doi: 10.1200/JCO.2008.18.7625.
    note
    Source null
    related pmid
    18779595
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2008 Oct 10;26(29):4848-9; author reply 4850-1. doi: 10.1200/JCO.2008.18.4218.
    note
    Source null
    related pmid
    18779597
    relationship
    Comment in

Authors and identifiers

  1. name
    Kelly K
    type
    Author
  2. name
    Chansky K
    type
    Author
  3. name
    Gaspar LE
    type
    Author
  4. name
    Albain KS
    type
    Author
  5. name
    Jett J
    type
    Author
  6. name
    Ung YC
    type
    Author
  7. name
    Lau DH
    type
    Author
  8. name
    Crowley JJ
    type
    Author
  9. name
    Gandara DR
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Kelly K
    type
    Author
  2. name
    Chansky K
    type
    Author
  3. name
    Gaspar LE
    type
    Author
  4. name
    Albain KS
    type
    Author
  5. name
    Jett J
    type
    Author
  6. name
    Ung YC
    type
    Author
  7. name
    Lau DH
    type
    Author
  8. name
    Crowley JJ
    type
    Author
  9. name
    Gandara DR
    type
    Author
bibliography ids
  1. nci-bib-94028f92e4540c2c104132a8
book metadata
content sha256
3fcbca2e805495a592639098112d33c36c95d5bc1e71b8237eea1df9c87b7633
document type
citation
dois
  1. 10.1200/JCO.2007.14.4824
electronic publication date
display
2008 Mar 31
precision
day
year
2008
evidence scope
bibliographic_metadata_only
id
pubmed:18378568
immutable id
pubmed:18378568@3fcbca2e805495a592639098112d33c36c95d5bc1e71b8237eea1df9c87b7633
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
15
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2450-6
volume
26
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2008 May 20;26(15):2428-30. doi: 10.1200/JCO.2008.16.0374.
    note
    Source null
    related pmid
    18378565
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2008 Oct 10;26(29):4849-50; author reply 4850-1. doi: 10.1200/JCO.2008.18.7625.
    note
    Source null
    related pmid
    18779595
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2008 Oct 10;26(29):4848-9; author reply 4850-1. doi: 10.1200/JCO.2008.18.4218.
    note
    Source null
    related pmid
    18779597
    relationship
    Comment in
outcomes validated
false
pmid
18378568
provenance
batch id
e663b4be92ee60a9b059
provider
NCBI PubMed ESummary
record sha256
7053ccc85a9e1a526cd608b3395e78197fbe17bfdce9827c2c00a03c1611286f
response sha256
514286e846d1566a3f75c88a4af66b82adfc16ee2368b19bce657f2237aba90d
retrieved at
2026-09-09T23:46:19.265979+00:00
publication date
display
2008 May 20
precision
day
year
2008
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, N.I.H., Extramural
  7. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/18378568/
title
Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023.

Preserved source evidence · Not medical advice